pSLQ8001 - pCMV-R8.91 (D64V) Citations (8)

Originally described in: Stable expression of large transgenes via the knock-in of an integrase-deficient lentivirus.
Chavez M, Rane DA, Chen X, Qi LS Nat Biomed Eng. 2023 May 1. doi: 10.1038/s41551-023-01037-x. PubMed Journal

---

Articles Citing pSLQ8001 - pCMV-R8.91 (D64V)

Articles
Targeted knock-in of NCF1 cDNA into the NCF2 locus leads to myeloid phenotypic correction of p47 (phox) -deficient chronic granulomatous disease. Siow KM, Gungor M, Wrona D, Raimondi F, Pastukhov O, Tsapogas P, Menzi T, Schmitz M, Kulcsar PI, Schwank G, Schulz A, Jinek M, Modlich U, Siler U, Reichenbach J. Mol Ther Nucleic Acids. 2024 May 24;35(3):102229. doi: 10.1016/j.omtn.2024.102229. eCollection 2024 Sep 10. PubMed
Targeting monocytic Occludin impairs transendothelial migration and HIV neuroinvasion. Brychka D, Ayala-Nunez NV, Dupas A, Bare Y, Partiot E, Mittelheisser V, Lucansky V, Goetz JG, Osmani N, Gaudin R. EMBO Rep. 2024 Aug;25(8):3276-3299. doi: 10.1038/s44319-024-00190-x. Epub 2024 Jul 22. PubMed
TFE3 fusions drive oxidative metabolism and ferroptosis resistance in translocation renal cell carcinoma. Helleux A, Davidson G, Lallement A, Hourani FA, Haller A, Michel I, Fadloun A, Thibault-Carpentier C, Su X, Lindner V, Tricard T, Lang H, Tannir NM, Davidson I, Malouf GG. EMBO Mol Med. 2025 May;17(5):1041-1070. doi: 10.1038/s44321-025-00221-7. Epub 2025 Mar 27. PubMed
Dual targeting of BCMA and SLAMF7 with the CARtein system: chimeric antigen receptors with intein-mediated splicing elicit specific T cell activation against multiple myeloma. Moares N, Gonzalez-Garcia P, Yi-He W, Munoz-Miranda JP, Gabucio A, Luna-Espejo R, Ocana-Cuesta J, Fernandez-Cisnal R, Fernandez-Ponce CM, Garcia-Cozar F. Front Immunol. 2025 Jul 31;16:1613222. doi: 10.3389/fimmu.2025.1613222. eCollection 2025. PubMed
Glycogen synthase kinase-3 is essential for T(reg) development and function. Kandasamy M, Andrew HF, Raza IG, Mitchell R, Borsa M, Valvo S, Ali M, Kronsteiner B, Attar M, Clarke AJ. Cell Rep. 2025 Sep 23;44(9):116256. doi: 10.1016/j.celrep.2025.116256. Epub 2025 Sep 11. PubMed
USP9X is a mechanosensitive deubiquitinase that controls tumor cell invasiveness and drug response through YAP stabilization. Biber P, Carminati A, Mohager W, Ohanna M, Girard CA, Lecacheur M, Kahil M, Bouvet O, Irondelle M, Audebert S, Khaled M, Tartare-Deckert S, Deckert M. Cell Rep. 2025 Oct 28;44(10):116372. doi: 10.1016/j.celrep.2025.116372. Epub 2025 Oct 1. PubMed
Intein-based modular chimeric antigen receptor platform for specific CD19/CD20 co-targeting. Gonzalez-Garcia P, Moares N, Yi-He W, Luna-Espejo R, Fernandez-Cisnal R, Ocana-Cuesta J, Munoz-Miranda JP, Gabucio A, Fernandez-Ponce CM, Garcia-Cozar F. Mol Oncol. 2025 Oct 13. doi: 10.1002/1878-0261.70146. PubMed
Oncostatin M induces epigenetic reprogramming in renal cell carcinoma-associated endothelial cells. Nguyen-Tran HH, Nguyen TN, Hsu T. Commun Biol. 2025 Nov 6;8(1):1541. doi: 10.1038/s42003-025-08907-x. PubMed

If you have published an article using this material, please email us at to have your article added to this page.